Related Experiment Video
Updated: Jan 30, 2026

Hierarchical and Programmable One-Pot Oligosaccharide Synthesis
Published on: September 6, 2019
Programmable Codelivery of Doxorubicin and Apatinib Using an Implantable Hierarchical-Structured Fiber Device for
Yang He1, Xilin Li1, Junkai Ma2
1Key Laboratory of Advanced Technologies of Materials, Ministry of Education, School of Materials Science and Engineering, Southwest Jiaotong University, Chengdu, 610031, China.
Abstract:
Multiple drug resistance (MDR) of cancer cells is a major cause of chemotherapy failure. It is currently a great challenge to develop a direct and effective strategy for continuously inhibiting the P-glycoprotein (P-gp) drug pump of MDR tumor cells, thus enhancing the intracellular concentration of the therapeutic agent for effectively killing MDR tumor cells. Here, a new implantable hierarchical-structured ultrafine fiber device is developed via a microfluidic-electrospinning technology for localized codelivery of doxorubicin (DOX) and apatinib (AP). An extremely high encapsulation efficiency of ≈99% for the dual drugs is achieved through this strategy. The release of the loaded dual drugs can be controlled in a programmable release model with a rapid release of the micelles, while AP is slowly released. The sustained release of AP can continuously inhibit the P-gp drug pump of MDR tumor cells, increasing the intracellular DOX accumulation. The in vivo DOX biodistribution displays that the DOX accumulation in the tumor tissues achieves 17.82% after implanting the fiber device for 72 h, which is 6.36-fold higher than that of the intravenously injected DOX. Importantly, the fiber device shows an excellent antitumor effect on MDR tumor-bearing mice with low systemic toxicity.
Insights
A novel implantable fiber device delivers doxorubicin and apatinib to combat multidrug-resistant (MDR) cancer. This localized therapy enhances drug accumulation in tumors, improving efficacy and reducing systemic toxicity.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapy
Background:
- Multidrug resistance (MDR) in cancer is a significant barrier to chemotherapy effectiveness.
- P-glycoprotein (P-gp) overexpression is a primary mechanism driving MDR, pumping therapeutic agents out of cancer cells.
- Developing strategies to overcome P-gp mediated drug efflux is crucial for improving cancer treatment outcomes.
Purpose of the Study:
- To develop an implantable device for localized co-delivery of doxorubicin (DOX) and apatinib (AP) to overcome MDR.
- To investigate the controlled release kinetics of DOX and AP from the device.
- To evaluate the in vivo efficacy and biodistribution of the dual-drug delivery system in MDR tumors.
Main Methods:
- Fabrication of a hierarchical-structured ultrafine fiber device using microfluidic-electrospinning technology.
- Encapsulation of doxorubicin (DOX) and apatinib (AP) with high efficiency (≈99%).
- In vitro characterization of drug release profiles and in vivo assessment of drug biodistribution and antitumor effects in MDR tumor models.
Main Results:
- The fiber device achieved high encapsulation efficiency for both DOX and AP.
- A programmable release model was observed, with rapid release of DOX and sustained release of AP.
- In vivo studies showed significantly enhanced DOX accumulation in tumor tissues (6.36-fold increase) and potent antitumor activity with low systemic toxicity.
Conclusions:
- The developed implantable fiber device offers a promising strategy for localized co-delivery of chemotherapy drugs.
- Sustained release of apatinib effectively inhibits P-gp, enhancing intracellular doxorubicin concentration and overcoming MDR.
- This approach demonstrates significant potential for improving the therapeutic efficacy of chemotherapy against MDR cancers.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
23:06The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Related Concept Videos
Treatment Resistant Cancers
Classification of Skeletal Muscle Fibers
Slow-Twitch Muscle Fibers
Slow oxidative, muscle fibers appear red due to large numbers of capillaries and high levels of...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Resistivity
Resistance
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...